Europace : European pacing, arrhythmias, and cardiac electrophysiology, ISSN 1099-5129, 2018, Volume 20, Issue 5, pp. 747 - 757
Aims: Contemporary data regarding atrial fibrillation (AF) management and current use of oral anticoagulants (OACs) for stroke prevention are needed. Methods...
Stroke | Registry | Epidemiology | Atrial fibrillation | Mortality | Thromboembolic risk | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | FOLLOW-UP | RISK | ADHERENCE | SOCIETY | ANTITHROMBOTIC TREATMENT | ORAL ANTICOAGULANTS | OUTCOMES | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Hemorrhage - prevention & control | Secondary Prevention - methods | Registries - statistics & numerical data | Platelet Aggregation Inhibitors - administration & dosage | Female | Stroke - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Atrial Fibrillation - complications | Europe - epidemiology | Anticoagulants - adverse effects | Outcome and Process Assessment (Health Care) | Stroke - etiology | Atrial Fibrillation - epidemiology | Survival Analysis | Aged | Hemorrhage - chemically induced
Stroke | Registry | Epidemiology | Atrial fibrillation | Mortality | Thromboembolic risk | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | FOLLOW-UP | RISK | ADHERENCE | SOCIETY | ANTITHROMBOTIC TREATMENT | ORAL ANTICOAGULANTS | OUTCOMES | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Hemorrhage - prevention & control | Secondary Prevention - methods | Registries - statistics & numerical data | Platelet Aggregation Inhibitors - administration & dosage | Female | Stroke - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Administration, Oral | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Atrial Fibrillation - complications | Europe - epidemiology | Anticoagulants - adverse effects | Outcome and Process Assessment (Health Care) | Stroke - etiology | Atrial Fibrillation - epidemiology | Survival Analysis | Aged | Hemorrhage - chemically induced
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2019
Abstract Aims Out-of-hospital cardiac arrest (OHCA) without return of spontaneous circulation (ROSC) despite conventional resuscitation is common and has poor...
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 02/2018, Volume 11, Issue 3, pp. 249 - 256
Objectives: This study sought to assess the relationship between an immediate invasive strategy and survival after an out-of-hospital cardiac arrest (OHCA) of...
sudden death | coronary angiogram | percutaneous coronary intervention | cardiac arrest | prognosis | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | EUROPEAN-RESUSCITATION-COUNCIL | RANDOMIZED CLINICAL-TRIAL | GUIDELINES | INTENSIVE-CARE MEDICINE | AMERICAN-HEART-ASSOCIATION | TEMPERATURE MANAGEMENT | HOSPITAL ADMISSION | TTM TRIAL | INTERVENTION
sudden death | coronary angiogram | percutaneous coronary intervention | cardiac arrest | prognosis | SURVIVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | EUROPEAN-RESUSCITATION-COUNCIL | RANDOMIZED CLINICAL-TRIAL | GUIDELINES | INTENSIVE-CARE MEDICINE | AMERICAN-HEART-ASSOCIATION | TEMPERATURE MANAGEMENT | HOSPITAL ADMISSION | TTM TRIAL | INTERVENTION
Journal Article
Circulation, ISSN 0009-7322, 07/2018, Volume 138, Issue 4, pp. 429 - 431
Journal Article
Circulation, ISSN 0009-7322, 07/2019, Volume 140, Issue 4, pp. 293 - 302
BACKGROUND:An accurate estimation of the risk of life-threatening (LT) ventricular tachyarrhythmia (VTA) in patients with LMNA mutations is crucial to select...
ARRHYTHMIAS | implantable | CARDIAC & CARDIOVASCULAR SYSTEMS | death | PREVENTION | ventricular | SUBDISTRIBUTION | HAZARDS MODEL | sudden | LAMIN A/C GENE | PERIPHERAL VASCULAR DISEASE | tachycardia | MUTATIONS | defibrillators | Tachycardia | Models | Health risk assessment | Risk factors | Life Sciences | Human health and pathology | Genetics | Cardiology and cardiovascular system
ARRHYTHMIAS | implantable | CARDIAC & CARDIOVASCULAR SYSTEMS | death | PREVENTION | ventricular | SUBDISTRIBUTION | HAZARDS MODEL | sudden | LAMIN A/C GENE | PERIPHERAL VASCULAR DISEASE | tachycardia | MUTATIONS | defibrillators | Tachycardia | Models | Health risk assessment | Risk factors | Life Sciences | Human health and pathology | Genetics | Cardiology and cardiovascular system
Journal Article
6.
Full Text
Should We Perform an Immediate Coronary Angiogram in All Patients After Cardiac Arrest?
JACC: Cardiovascular Interventions, ISSN 1936-8798, 02/2018, Volume 11, Issue 3, pp. 249 - 256
This study sought to assess the relationship between an immediate invasive strategy and survival after an out-of-hospital cardiac arrest (OHCA) of presumed...
sudden death | coronary angiogram | percutaneous coronary intervention | cardiac arrest | prognosis
sudden death | coronary angiogram | percutaneous coronary intervention | cardiac arrest | prognosis
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2013, Volume 71, Issue Suppl 3, pp. 46 - 46
Remission has become in the last few years an accessible objective in the management of rheumatoid arthritis (RA) patients due to treatment improvement and the...
Journal Article
Cardiovascular Research, ISSN 0008-6363, 03/2012, Volume 93, Issue suppl 1, pp. S92 - S127
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 21, pp. 2299 - 2307
Abstract Background Mutations in LMNA are variably expressed and may cause cardiomyopathy, atrioventricular block (AVB), or atrial arrhythmias (AAs) and...
Cardiovascular | Internal Medicine | heart failure | atrial fibrillation | genetics | ventricular tachycardia | cardiomyopathy | complete atrioventricular block | GENE-MUTATIONS | CONDUCTION-SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | complete atrioventricular | SUDDEN-DEATH | PREVENTION | RISK | DILATED CARDIOMYOPATHY | VENTRICULAR-ARRHYTHMIAS | DISEASE | block | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | COMPLICATIONS | Prevalence | Prognosis | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Male | Arrhythmias, Cardiac - physiopathology | Incidence | Young Adult | Time Factors | Adult | Female | Ventricular Function, Left - physiology | Retrospective Studies | Arrhythmias, Cardiac - genetics | Arrhythmias, Cardiac - epidemiology | France - epidemiology | Survival Rate - trends | Lamin Type A - metabolism | Adolescent | Lamin Type A - genetics | Victoria - epidemiology | Aged | Mutation | Arrhythmia | Cardiology | Genetic aspects | Heart failure | Variables | Cardiac arrhythmia | Genotype & phenotype | Cardiomyopathy | Mortality | Kinases | Deoxyribonucleic acid--DNA | Muscular dystrophy
Cardiovascular | Internal Medicine | heart failure | atrial fibrillation | genetics | ventricular tachycardia | cardiomyopathy | complete atrioventricular block | GENE-MUTATIONS | CONDUCTION-SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | complete atrioventricular | SUDDEN-DEATH | PREVENTION | RISK | DILATED CARDIOMYOPATHY | VENTRICULAR-ARRHYTHMIAS | DISEASE | block | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | COMPLICATIONS | Prevalence | Prognosis | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Male | Arrhythmias, Cardiac - physiopathology | Incidence | Young Adult | Time Factors | Adult | Female | Ventricular Function, Left - physiology | Retrospective Studies | Arrhythmias, Cardiac - genetics | Arrhythmias, Cardiac - epidemiology | France - epidemiology | Survival Rate - trends | Lamin Type A - metabolism | Adolescent | Lamin Type A - genetics | Victoria - epidemiology | Aged | Mutation | Arrhythmia | Cardiology | Genetic aspects | Heart failure | Variables | Cardiac arrhythmia | Genotype & phenotype | Cardiomyopathy | Mortality | Kinases | Deoxyribonucleic acid--DNA | Muscular dystrophy
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2017, Volume 38, Issue suppl_1
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2016, Volume 75, Issue 1, pp. 59 - 67
Tumour necrosis factor (TNF)-blocker tapering has been proposed for patients with rheumatoid arthritis (RA) in remission.ObjectiveThe trial aims to compare the...
CLINICAL REMISSION | SEDIMENTATION-RATE | LOW DISEASE-ACTIVITY | INDUCTION THERAPY | TASK-FORCE | NECROSIS-FACTOR INHIBITORS | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | ADALIMUMAB PLUS METHOTREXATE | INFLIXIMAB | EULAR RECOMMENDATIONS | Severity of Illness Index | Recurrence | Etanercept - adverse effects | Drug Administration Schedule | Etanercept - administration & dosage | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Adalimumab - adverse effects | Arthritis, Rheumatoid - diagnostic imaging | Radiography | Adalimumab - administration & dosage | Maintenance Chemotherapy - methods | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adult | Female | Aged | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Dosage and administration | Tumor necrosis factor | Rheumatoid arthritis | Analysis | Life Sciences | Human health and pathology | Rhumatology and musculoskeletal system
CLINICAL REMISSION | SEDIMENTATION-RATE | LOW DISEASE-ACTIVITY | INDUCTION THERAPY | TASK-FORCE | NECROSIS-FACTOR INHIBITORS | ANKYLOSING-SPONDYLITIS | RHEUMATOLOGY | ADALIMUMAB PLUS METHOTREXATE | INFLIXIMAB | EULAR RECOMMENDATIONS | Severity of Illness Index | Recurrence | Etanercept - adverse effects | Drug Administration Schedule | Etanercept - administration & dosage | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Adalimumab - adverse effects | Arthritis, Rheumatoid - diagnostic imaging | Radiography | Adalimumab - administration & dosage | Maintenance Chemotherapy - methods | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adult | Female | Aged | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Dosage and administration | Tumor necrosis factor | Rheumatoid arthritis | Analysis | Life Sciences | Human health and pathology | Rhumatology and musculoskeletal system
Journal Article